Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CRBP Corbus Pharmaceuticals

Pre-Mkt 11-04 05:50:42 EST

3.87

-0.04

-1.15%

盘前3.90

+0.03+0.78%

05:16 EST

High4.11	Low3.73	Vol4.37M
Open3.92	D1 Closing3.92	Amplitude9.71%
Mkt Cap74.85M	Tradable Cap51.27M	Total Shares19.34M
T/O16.80M	T/O Rate32.97%	Tradable Shares13.25M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CRBP","market":"US","secType":"STK","nameCN":"Corbus Pharmaceuticals","latestPrice":3.87,"timestamp":1793739600000,"preClose":3.915,"halted":0,"volume":4367646,"hourTrading":{"tag":"盘前","latestPrice":3.9,"preClose":3.87,"latestTime":"05:16 EST","volume":116,"amount":459.54881320000004,"timestamp":1793787361331,"change":0.03,"changeRate":0.007752,"amplitude":0.115452},"delay":0,"changeRate":-0.011494252873563201,"floatShares":13248200,"shares":19341300,"eps":-6.088859,"marketStatus":"Pre-Mkt","change":-0.045,"latestTime":"11-04 05:50:42 EST","open":3.92,"high":4.11,"low":3.73,"amount":16801958.544444,"amplitude":0.097063,"askPrice":4.77,"askSize":100,"bidPrice":3.51,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-6.088859,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1793802600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.87,"preHourTrading":{"tag":"盘前","latestPrice":3.9,"preClose":3.87,"latestTime":"05:16 EST","volume":116,"amount":459.54881320000004,"timestamp":1793787361331,"change":0.03,"changeRate":0.007752,"amplitude":0.115452},"postHourTrading":{"tag":"盘后","latestPrice":3.87,"preClose":3.87,"latestTime":"19:30 EST","volume":287,"amount":1113.85,"timestamp":1793752204305,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":3.6756862930305845,"impliedVol":2.2337,"impliedVolPercentile":0.94},"requestUrl":"/m/hq/s/CRBP","defaultTab":"news","newsList":[{"id":"2680765703","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2680765703","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680765703?lang=en_us&edition=fundamental","pubTime":"2026-11-04 06:19","pubTimestamp":1793744340,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  shed 1.15% to $3.87 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.83% to 25,372.01 and the Dow Jones Industrial Average  falling 0.38% to 51,786.72.This was the stock's second consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 69.96% below its 52-week high of $12.88, which the company achieved on May 22nd.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc.  fell 3.35% to $3.75, Fortress Biotech Inc.  rose 0.52% to $1.94, and Viking Therapeutics Inc.  fell 2.76% to $26.09.Trading volume  eclipsed its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680795186","title":"Corbus Pharmaceuticals Holdings Inc. Stock Sheds 7.2%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2680795186","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680795186?lang=en_us&edition=fundamental","pubTime":"2026-11-03 05:34","pubTimestamp":1793655240,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. shed 7.2% to $3.92 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.4% to 51,983.98 and the NASDAQ Composite Index falling 1.1% to 25,164.32.Corbus Pharmaceuticals Holdings Inc. closed 69.6% short of its 52-week high of $12.88, which the company achieved on May 22nd.The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. rose 2.4% to $3.88, Fortress Biotech Inc. rose 0.5% to $1.93, and Viking Therapeutics Inc. fell 1.65% to $26.83.Trading volume totaled 672,978, compared to the 50-day average of 1.1 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680798126","title":"Cormorant Global Healthcare Master Fund Reports Sale of $1.74 Million in Corbus Pharmaceuticals Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2680798126","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680798126?lang=en_us&edition=fundamental","pubTime":"2026-11-03 05:06","pubTimestamp":1793653595,"startTime":"0","endTime":"0","summary":"Cormorant Global Healthcare Master Fund Reports Sale of $1.74 Million in Corbus Pharmaceuticals Common SharesCormorant Asset Management reported a sale of 425,000 Corbus Pharmaceuticals common shares ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261102:nNDLc6R38F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Cormorant Global Healthcare Master Fund Reports Sale of $1.74 Million in Corbus Pharmaceuticals Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679417263","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2679417263","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679417263?lang=en_us&edition=fundamental","pubTime":"2026-10-29 05:20","pubTimestamp":1793222400,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rose 2.41% to $4.25 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.27% to 26,549.85 and the Dow Jones Industrial Average  rising 0.19% to 52,475.10.This was the stock's second consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 76.53% below its 52-week high of $18.11, which the company reached on October 28th.The stock outperformed some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  rose 0.25% to $4.00, Fortress Biotech Inc.  rose 1.55% to $1.96, and Viking Therapeutics Inc.  rose 1.89% to $25.36.Trading volume  remained 261,487 below its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 2","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678114911","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2678114911","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678114911?lang=en_us&edition=fundamental","pubTime":"2026-10-27 05:20","pubTimestamp":1793049600,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  shed 1.48% to $3.99 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 0.82% to 26,169.38 and the Dow Jones Industrial Average  rising 0.28% to 52,361.58.This was the stock's sixth consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 77.97% short of its 52-week high of $18.11, which the company reached on October 28th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc.  fell 1.75% to $3.94, Fortress Biotech Inc.  fell 3.11% to $1.87, and Viking Therapeutics Inc.  fell 0.78% to $24.21.Trading volume  remained 159,578 below its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677970804","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2677970804","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677970804?lang=en_us&edition=fundamental","pubTime":"2026-10-24 05:18","pubTimestamp":1792790280,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slipped 1.94% to $4.05 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index  falling 0.21% to 25,955.34 and Dow Jones Industrial Average  falling 1.23% to 52,215.16.This was the stock's fifth consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 77.64% short of its 52-week high of $18.11, which the company reached on October 28th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc.  fell 0.99% to $4.01, Fortress Biotech Inc.  fell 3.02% to $1.93, and Viking Therapeutics Inc.  fell 5.54% to $24.40.Trading volume  remained 640,850 below its 50-day average volume of 1.0 M.Data source: Dow Jones Market Da","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677996886","title":"Corbus Plans CRB-913 Phase 1b Obesity Trial Data Presentation at Obesity Week 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2677996886","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677996886?lang=en_us&edition=fundamental","pubTime":"2026-10-22 20:00","pubTimestamp":1792670458,"startTime":"0","endTime":"0","summary":"Corbus Plans CRB-913 Phase 1b Obesity Trial Data Presentation at Obesity Week 2026Corbus Pharmaceuticals will present CRB-913 Phase 1b CANYON-1 study data at Obesity Week on November 15, 2026, in Nati","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nNDLbHGw6T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BQXX3D17.EUR","IE00BKPKM429.USD","BK4588","CRBP","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","BK4112","LU2210150020.SGD","SG9999014021.USD","SG9999014039.USD","BK4585","IE00BQXX3F31.USD","LU2210149790.SGD","IE00BGHQF748.EUR","NDAQ","LU0314104364.USD","BCDF","SG9999014013.SGD","BK4139","LU2095319765.USD","IE00BN0W2V16.EUR","SG9999014005.SGD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677600408","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2677600408","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677600408?lang=en_us&edition=fundamental","pubTime":"2026-10-22 05:20","pubTimestamp":1792617600,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  shed 3.05% to $4.29 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 1.05% to 26,702.86 and the Dow Jones Industrial Average  rising 0.69% to 52,856.09.This was the stock's third consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 78.58% short of its 52-week high of $20.00, which the company reached on October 21st.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  fell 3.84% to $4.01, Fortress Biotech Inc.  remained unchanged, and Viking Therapeutics Inc.  fell 1.24% to $26.38.Trading volume  remained 375,355 below its 50-day average volume of 1.0 M.Data source: Dow Jones Market","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676639108","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2676639108","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676639108?lang=en_us&edition=fundamental","pubTime":"2026-10-20 05:21","pubTimestamp":1792444860,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slid 1.33% to $4.46 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 1.11% to 26,430.89 and the Dow Jones Industrial Average  falling 0.07% to 51,966.03.Corbus Pharmaceuticals Holdings Inc. closed 78.31% below its 52-week high of $20.56, which the company achieved on October 20th.The stock underperformed when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc.  rose 1.49% to $4.09, Fortress Biotech Inc.  rose 0.54% to $1.87, and Viking Therapeutics Inc.  fell 0.48% to $25.05.Trading volume  remained 255,633 below its 50-day average volume of 990,374.Data source: Dow Jones Market Data, FactSet. Data compiled October 19, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675355891","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2675355891","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675355891?lang=en_us&edition=fundamental","pubTime":"2026-10-16 05:18","pubTimestamp":1792099080,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slid 1.81% to $4.33 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.08% to 26,713.03 and the Dow Jones Industrial Average  rising 1.08% to 52,177.69.This was the stock's fourth consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 78.94% short of its 52-week high of $20.56, which the company reached on October 20th.The stock underperformed when compared to some of its competitors Thursday, as Vanda Pharmaceuticals Inc.  rose 0.47% to $4.24, Fortress Biotech Inc.  rose 0.53% to $1.91, and Viking Therapeutics Inc.  rose 7.46% to $27.37.Trading volume  eclipsed its 50-day average volume of 955,151.Data source: Dow Jones Market Data, FactSet. Data comp","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675535430","title":"Corbus Pharmaceuticals Updates Oncology and Obesity Pipeline Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2675535430","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675535430?lang=en_us&edition=fundamental","pubTime":"2026-10-15 22:48","pubTimestamp":1792075692,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals ( ($CRBP) ) has provided an announcement. On October 15, 2026, Corbus Pharmaceuticals updated its corporate presentation out...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/corbus-pharmaceuticals-updates-oncology-and-obesity-pipeline-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/corbus-pharmaceuticals-updates-oncology-and-obesity-pipeline-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675606383","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2675606383","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675606383?lang=en_us&edition=fundamental","pubTime":"2026-10-14 05:21","pubTimestamp":1791926460,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slid 9.30% to $4.78 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 0.15% to 27,204.38 and Dow Jones Industrial Average  falling 0.35% to 51,670.10.This was the stock's second consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 76.75% short of its 52-week high of $20.56, which the company reached on October 20th.The stock underperformed when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc.  fell 5.29% to $4.30, Fortress Biotech Inc.  fell 7.58% to $1.95, and Viking Therapeutics Inc.  fell 5.96% to $26.65.Trading volume  remained 274,916 below its 50-day average volume of 923,194.Data source: Dow Jones Market Data, FactSet. Dat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675883253","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2675883253","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675883253?lang=en_us&edition=fundamental","pubTime":"2026-10-13 05:19","pubTimestamp":1791839940,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  shed 2.04% to $5.27 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.38% to 51,850.55 and the NASDAQ Composite Index  falling 0.44% to 27,245.90.Corbus Pharmaceuticals Holdings Inc. closed 74.37% below its 52-week high of $20.56, which the company reached on October 20th.The stock underperformed when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc.  fell 0.66% to $4.54, Fortress Biotech Inc.  fell 1.17% to $2.11, and Viking Therapeutics Inc.  fell 0.60% to $28.34.Trading volume  eclipsed its 50-day average volume of 910,013.Data source: Dow Jones Market Data, FactSet. Data compiled October 12, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674586590","title":"Corbus’s CRB-913 Obesity Trial Reaches Key Phase 1b Milestone, Putting CRBP on Investors’ Radar","url":"https://stock-news.laohu8.com/highlight/detail?id=2674586590","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674586590?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:31","pubTimestamp":1791563461,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals Holdings ($CRBP) announced an update on their ongoing clinical study. Corbus Pharmaceuticals Inc. is advancing its obesity p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/corbuss-crb-913-obesity-trial-reaches-key-phase-1b-milestone-putting-crbp-on-investors-radar?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/corbuss-crb-913-obesity-trial-reaches-key-phase-1b-milestone-putting-crbp-on-investors-radar?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4211","ISBC","CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674888265","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2674888265","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674888265?lang=en_us&edition=fundamental","pubTime":"2026-10-09 05:19","pubTimestamp":1791494340,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  shed 4.01% to $5.27 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.10% to 51,231.64 and the NASDAQ Composite Index  falling 1.25% to 27,193.34.This was the stock's sixth consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 74.37% below its 52-week high of $20.56, which the company achieved on October 20th.The stock underperformed when compared to some of its competitors Thursday, as Vanda Pharmaceuticals Inc.  fell 0.66% to $4.53, Fortress Biotech Inc.  rose 2.45% to $2.09, and Viking Therapeutics Inc.  fell 2.84% to $27.73.Trading volume  eclipsed its 50-day average volume of 873,687.Data source: Dow Jones Market Data, FactSet. Data compiled ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673065049","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673065049","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673065049?lang=en_us&edition=fundamental","pubTime":"2026-10-07 05:21","pubTimestamp":1791321660,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slid 1.20% to $5.78 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.45% to 27,599.79 and the Dow Jones Industrial Average  rising 0.49% to 51,521.28.This was the stock's fourth consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 71.89% short of its 52-week high of $20.56, which the company achieved on October 20th.Despite its losses, the stock outperformed some of its competitors Tuesday, as Vanda Pharmaceuticals Inc.  fell 1.31% to $4.52, Fortress Biotech Inc.  fell 1.91% to $2.05, and Viking Therapeutics Inc.  fell 3.07% to $28.38.Trading volume  remained 138,503 below its 50-day average volume of 845,062.Data source: Dow Jones Market Data, FactSe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084619","title":"Corbus Pharmaceuticals Holdings Inc. Stock Sheds 4.6%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084619","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084619?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:34","pubTimestamp":1791232440,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. slid 4.6% to $5.85 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 27,477.31 and the Dow Jones Industrial Average rising 0.2% to 51,267.90.This was the stock's third consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 71.5% below its 52-week high of $20.56, which the company achieved on October 20th.The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 1.1% to $4.58, Fortress Biotech Inc. rose 3.0% to $2.09, and Viking Therapeutics Inc. fell 2.20% to $29.28.Trading volume totaled 783,291, compared to the 50-day average of 832,647.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672741504","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2672741504","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672741504?lang=en_us&edition=fundamental","pubTime":"2026-10-03 05:21","pubTimestamp":1790976060,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slipped 3.31% to $6.13 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 1.19% to 27,190.86 and the Dow Jones Industrial Average  rising 0.49% to 51,176.96.This was the stock's second consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 70.18% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc.  fell 3.74% to $4.63, Fortress Biotech Inc.  fell 1.93% to $2.03, and Viking Therapeutics Inc.  fell 1.87% to $29.94.Trading volume  eclipsed its 50-day average volume of 828,735.Data source: Dow Jones Market Data, FactS","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672787019","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2672787019","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672787019?lang=en_us&edition=fundamental","pubTime":"2026-10-01 05:22","pubTimestamp":1790803320,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  advanced 2.87% to $6.82 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.24% to 26,861.06 and the Dow Jones Industrial Average  falling 0.86% to 50,906.05.The stock's rise snapped a five-day losing streak.Corbus Pharmaceuticals Holdings Inc. closed 66.83% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock outperformed some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  fell 2.39% to $4.91, Fortress Biotech Inc.  fell 2.73% to $2.14, and Viking Therapeutics Inc.  rose 2.48% to $32.60.Trading volume  remained 300,620 below its 50-day average volume of 807,220.Data source: Dow Jones Market Data, FactSet. Data compiled Septe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211398","title":"Corbus Pharmaceuticals Announces First Patient Dosed in Tempo-1 Registrational Study of Crb-701 in Patients with 2L+ Oropharyngeal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211398","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211398?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683207,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUAFLNLX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corbuspharma.com","stockEarnings":[{"period":"1week","weight":-0.0675},{"period":"1month","weight":-0.3687},{"period":"3month","weight":-0.5956},{"period":"6month","weight":-0.644},{"period":"1year","weight":-0.6854},{"period":"ytd","weight":-0.5246}],"compareEarnings":[{"period":"1week","weight":-0.0199},{"period":"1month","weight":-0.0199},{"period":"3month","weight":-0.0201},{"period":"6month","weight":0.0311},{"period":"1year","weight":0.1039},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.363358},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.048678},{"month":3,"riseRate":0.636364,"avgChangeRate":0.197993},{"month":4,"riseRate":0.545455,"avgChangeRate":0.046477},{"month":5,"riseRate":0.583333,"avgChangeRate":0.055971},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.044414},{"month":7,"riseRate":0.25,"avgChangeRate":-0.049826},{"month":8,"riseRate":0.666667,"avgChangeRate":0.105723},{"month":9,"riseRate":0.25,"avgChangeRate":-0.110488},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.145709},{"month":11,"riseRate":0.666667,"avgChangeRate":0.112305},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.132264}],"exchange":"NASDAQ","name":"Corbus Pharmaceuticals","nameEN":"Corbus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Corbus Pharmaceuticals(CRBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Corbus Pharmaceuticals,CRBP,Corbus Pharmaceuticals股票,Corbus Pharmaceuticals股票老虎,Corbus Pharmaceuticals股票老虎国际,Corbus Pharmaceuticals行情,Corbus Pharmaceuticals股票行情,Corbus Pharmaceuticals股价,Corbus Pharmaceuticals股市,Corbus Pharmaceuticals股票价格,Corbus Pharmaceuticals股票交易,Corbus Pharmaceuticals股票购买,Corbus Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Corbus Pharmaceuticals(CRBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}